Alveolus Bio

Alveolus Bio

  • Founded: 2021
  • Location: Birmingham, AL
  • Employee range: 1 - 10
  • Clinical stage: Clin0
  • Therapy area: COPD
  • Drug types: LNG
  • Lead product: AB1000
  • Product link:

job board

Short description:

Commensal bacteria as lung therapy

Drug notes:

also RD bronchopulmonary dysplasia, pulmonary fibrosis

Long description:

Alveolus Bio is a clinical phase company creating therapeutics for chronic lung disease with an interdisciplinary team of experts in respiratory medicine and microbiome science. Their pre-clinical programs include inhalable, live biotherapeutic products for Chronic Obstructive Pulmonary Disease (COPD), Bronchopulmonary Dysplasia (BPD), Pulmonary Fibrosis, lung injury secondary to viral illness, and Neutrophilic Asthma. Since microbial signature changes in the lungs are associated with inflammation and respiratory disease progression, Alveolus Bio attempts to use anti-inflammatory commensal bacteria strains and byproducts as a direct, inhalable treatment for lung disease.


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy